Oct. 22, 2025 —  Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 Endoscopic Imaging System — a smartly designed single-unit processor and light source (EP-8000) featuring several features that enhance endoscopic image quality, therapeutic capabilities, and workflow efficiencies. The next-generation platform will be demonstrated at the American College of Gastroenterology (ACG) 2025 Oct.r 26 -28, in Phoenix, Arizona.

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the University of Exeter.

Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in neurology offices in the United States, marking a major milestone in the company’s mission to transform how clinicians monitor the effectiveness of treatment for dementia, Alzheimer’s, Parkinson's and other neurological conditions. 

New Report: Radiotherapy Contributes to 40% of All Cancer Cures

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and attention, according to a new impact report released at the American Society for Radiation Oncology’s (ASTRO) 67thAnnual Meeting.

Oct. 9, 2025 — Harrison.ai has received three FDA Breakthrough Device Designations for CT imaging solutions, further solidifying its position at the forefront of next-generation AI for driving efficient, quality patient care.

Oct. 21, 2025 — GT Medical Technologies has announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of Resection [Surgery] and GammaTile versus Standard of Care) in patients with operable, newly diagnosed brain metastases.1

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive findings from a proof-of-concept (POC) study with Bayer evaluating Subtle Medical's investigational SubtleGAD technology.

Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced digital innovation and medical technologies to the health system to deliver high-quality, timely and consistent care that meets the individual patient’s health care needs.

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care teams identify, prioritize, and act on critical patient data.1 Viz Assist marks a major step forward in Viz.ai’s mission to use technology to reduce time to treatment and improve patient outcomes.

Oct. 6, 2025 — GE HealthCare has announced a strategic collaboration with Erasmus MC University Medical Center (Erasmus MC) to evaluate a next-generation total body positron emission tomography / computed tomography (PET/CT) technology[i] that aims to provide new opportunities to support confident disease detection, treatment planning, and patient outcome monitoring.

Erasmus MC University Medical Center is a teaching hospital based in Rotterdam, Netherlands.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now